Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: J Pharm Pharmacol. 2010 Jan;62(1):145–151. doi: 10.1211/jpp.62.01.0017

Figure 1. JS-K inhibits HUVEC growth.

Figure 1

HUVEC were cultured with the indicated concentrations of JS-K. At the indicated time points cell growth was scored as outlined in the Methods section. JS-K treatment led to a dose-dependent inhibition of HUVEC growth. The IC50 at 24, 48, and 72 hours was 0.432, 0.466, and 0.505 µM, respectively. (Averages and SEM of 3 separate experiments).